Bonus BioGroup Ltd. (TASE:BONS) announced that it has entered into an investment agreement for private placement of 11,428,571 common shares at ILS 0.7 per share for gross proceeds of ILS 7,999,999.7 on October 5, 2016. The transaction will include participation from new investor. The company will also issue 11,428,571 warrants in the transaction. Each warrant entitles the holder to acquire one common share at ILS 0.90 per share within 30 days from the date of allotment. The investor will acquire about 1.45% stake in the company. The shares will not be issued at its par value. The securities issued are subject to hold period of six months before listing after the date of allotment. The transaction is subject to board of directors’ approval of the company.